Rakovina Therapeutics, Celvion Therapeutics Ink Precision Cancer Drug Development Pact

Rakovina Therapeutics and Celvion Therapeutics are partnering to utilize AI and real-world clinical data to advance precision cancer drug development, focusing on identifying optimal combination therapies, predictive biomarkers, and patient populations for Rakovina's ATR inhibitor program.